https://www.selleckchem.com/products/CHIR-258.html
023 from baseline; n = 20 of 39 of those initially in remission). This was comparable to the NDC group (1,016 [857-1,507] pmol/min/m2) by 12 (P = 0.064) and 24 (P = 0.244) months. Median first-phase insulin response increased from baseline to 5 months (42 [4-67] to 107 [59-163] pmol/min/m2; P less then 0.0001) and then remained stable at 12 and 24 months (110 [59-201] and 125 [65-166] pmol/min/m2, respectively; P less then 0.0001 vs. baseline) but lower than that of the NDC group (250 [226-429] pmol/min/m2; P less then 0.0001). CONCLUS
Like
Comment
Share
